Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)
Fed Focused on Labor Market for Rate Hike Path: Wilson
27:15 - Andrew Wilson, chief executive officer for EMEA at Goldman Sachs Asset Management, discusses the Federal Reserve policy report and how the labor market plays into when and how the Fed raises interest rates. He speaks on "On The Move." (Source: Bloomberg)
  • What Burgers Can Say About the Spanish Economy
  • BNP Paribas Said to Weigh Revamp of Securities Unit
  • Deutsche Bank 2Q Profit More Than Triples